Hexoskin's co-founder and CEO Pierre-Alexandre Fournier has been invited this year again to talk about wearable vital signs monitoring and digital biomarker development at the Biosensors for Medical Wearables Conference in Boston, this October 23rd.
Vital signs sensors traditionally used for cardiac and respiratory monitoring involve adhesives or tape to keep sensors in place on the skin. Experience has shown there's a tradeoff between monitoring duration (1 to 14 days), and adhesive agressiveness, which can lead to skin rashes or wounds.
There's now a safer and more convenient way for patients to record long-term vital signs data needed for diagnosis or digital biomarker development: smart textiles. Hexoskin users have successfully demonstrated the advantages of using a form factor that patients like. Researchers have documented it in over 200 scientific papers.
Moreover, Hexoskin biometric shirts' respiratory sensors allow continuous pulmonary measurements previously hard or impossible to collect in real-world situations, outside laboratory environments. These sensors open a new era of research on diseases that have an impact on the pulmonary function.
In his talk, Fournier will describe medical applications of smart textile sensors for patients with respiratory diseases, as well as opportunities in research in cardiology, mental health and rare diseases. He will also share unique insights into Hexoskin's experience in space medicine research aboard the International Space Station.
Please reach out for more information: email@example.com
In this video interview with HITLAB at Columbia University in New York, Hexoskin's CEO Pierre-Alexandre Fournier discusses how fundamental building medical data infrastructure was to enable automation and AI - tools to make healthcare delivery more efficient and more accessible.
The lack of electronic medical records and data standards has slowed progress in digital health and AI in the 2000s and 2010s. Today the infrastructure is ready to make data collected by patients actionable and valuable.
This new IT environment (EHR/EMRs, broadband, FIRH, HL7, smart phones, and wearables) accelerates automation and AI development, digital biomarker discovery, personalized medicine and new health prevention services.
Hexoskin is building on this infrastructure to offer high-resolution vital signs monitoring with Hexoskin and Astroskin wearables, apps to collect patient reported outcomes and events, could storage, data automation and cohort management.
Please reach out to see how Hexoskin can help.
Dr. Martin Gershon, Managing Partner/CIO of Endeavor Venture Fund and physician entrepreneur, had a 30 minutes conversation today with Hexoskin's CEO Pierre-Alexandre Fournier.
They talked about the journey of Hexoskin and the new landscape for medical wearables, connected sensors, digital biomarkers, the future of diagnostics and clinical research. They also emphasized the importance of collaboration and community to build innovative solutions that benefit patients, caregivers, and providers.
The live webinar recording is available below.
Our CEO Pierre-Alexandre Fournier presented some of Hexoskin's efforts to solve the evidence gap for healthcare and clinical trials at Columbia University last month, and HITLAB recently made the 15 minutes video available online below.
Clinical evidence is what makes medical discoveries possible: that's how we measure safety and efficacy, and that's how we measure efficiency gains in healthcare delivery. When we lower the cost of evidence, we make care more accessible and affordable. This is an important part of our mission at Hexoskin.
In the video you'll see a few examples of our work at Hexoskin, from clinical research to AI development to human spaceflight.
The Hexoskin and Astroskin platform has been used to collect health data for over 200 scientific publications. White papers about wearable sensors applications for health monitoring of are available upon request.
Hexoskin's co-founder and CEO, Pierre-Alexandre Fournier, has been invited to speak at the prestigious HITLAB Innovator Summit 2023, hosted at Columbia University in New York City this June 27-29.
In the past 10 years we have seen enormous progress in the use of digital technologies in healthcare to support a wide range of activities: remote care, remote diagnostics, access to medical data, artificial intelligence, virtual clinical trials, genetic analysis, digital biomarker development, molecule discovery, etc. Despite all this progress, patients, physicians, scientists and researchers agree we have barely started to use digital tools to address our growing need for efficient healthcare, therapies and population health management.
The event includes speakers from Merck, Takeda, Pfizer, Syneos, Medidata, CVS, Novo Nordisk, Microsoft, Mount Sinai Health System, Brigham and Women’s Hospital, and many other organizations working to improve human health and access to care.
Please reach out to us if you'd like to arrange a meeting during the event: firstname.lastname@example.org
Tickets are still available, and you can get 20% off with the special code SUMMITPAF23.
Founded in 2006 in Montreal, Hexoskin is a leader in wearable sensors, software, data science & AI services. The company provides solutions and services to researchers & professionals in pharmaceuticals, academics, healthcare, defense, first responders, space, and aerospace organizations.
In this episode of the Bleeding Edge of Digital Health, host Mike Moore speaks with entrepreneur, scientist, and co-founder of Hexoskin, Pierre-Alexander Fournier.
Mike and Pierre talk about how his latest tech garment is being utilized in health care today, how it is benefiting not just the patient but the physician as well, and more importantly, the future products and garments in Hexoskin’s pipeline that will pave the way for further innovation and change the way we take care of our health, and the health of the ones we care about. Be sure to listen to the entire session.
“So, we're working on different garments. We do have another product that has more sensors called the Astroskin that is being used in research, and that's the product that is being used in the space station right now for different research projects in microgravity. The Astroskin is the model Chris Hemsworth is wearing in Limitless.”
“Research groups we're working with have built the largest database of vital signs for many specific health conditions. So, there are a lot of things that will come out of it. And as I said earlier, we're not just building a product for single use. Eventually, we're going to add blocks to that platform so that it can be used for several types of disease, and it's going to become a great bundle for people with comorbidities.”
The Canadian Space Agency (CSA) has awarded contracts to five teams to build prototypes of the Connected Care Medical Module (C²M²), a container-based concept for mobile medical clinics that can be rapidly deployed in remote, northern, or indigenous communities across Canada, in regions affected by natural disasters, and in future lunar and deep space missions.
Hexoskin (Carré Technologies Inc.) is proud to be part of the HARMONY team, led by CGI, one of the largest IT firms in the world, along with OKAKI Health Intelligence, PrecisionOS Technology, 12Volt: Games Studio, and Dr. Carolyn McGregor of the University of Ontario Institute of Technology.
Health Beyond's vision is to enable agile, rapid prototyping and iterative operation of C²M²s on Earth, with the ultimate objective of operation in space. A C²M² is a scalable integrated system of state-of-the-art medical technologies and methodologies contained in a deployable unit. A shipping container will first be used for research and development purposes and for easy deployment across Canada via the existing intermodal freight transportation network. When preparing for space application and deployment in remote communities with collaborators, the medical module can be scaled down and adapted as needed.
One of the novel features of the C²M² is its core computer-based system that facilitates the incorporation, interconnection (i.e., flow of information), and usage of the latest medical technologies. This plug and play architecture will enable multiple configurations based on the end users' needs. These technologies increase the user's capacity to independently detect, diagnose, treat, and/or monitor health conditions on site. This improves the timeliness, quality, and continuity of care; refines clinical decision-making; and reduces the occurrence of risky and expensive medical transportation of patients from remote regions to urban hospital facilities.
(photo: Canadian Space Agency)
Hexoskin's co-founder and CEO Pierre-Alexandre Fournier has been invited to talk about long-term vital signs monitoring at the Biosensors for Medical Wearables Conference in Boston on October 25th.
Vital signs sensors traditionally used for cardiac and respiratory monitoring involve adhesives or tape to keep the sensors in place on the skin. Experience has shown there's a tradeoff between monitoring duration (1 to 14 days), and adhesive agressiveness, which can lead to skin rashes or wounds.
There's now a safer and more convenient way for patients to record long-term vital signs data needed for diagnosis or to guide care or rehabilitation: smart textiles. Hexoskin users have successfully demonstrated the advantages of using a form factor that patients like. Researchers have documented it in over 200 scientific papers.
In his talk, Fournier will describe medical applications of smart textile sensors for patients with cardiac and respiratory diseases, as well as opportunities in research in mental health and rare diseases. He will also share unique insights into Hexoskin's experience in space medicine research aboard the International Space Station.
Please reach out for more information: email@example.com
Hexoskin's CEO Pierre-Alexandre Fournier was invited to speak at a seminar co-hosted by Stanford eWEAR and Stanford Medicine's Precision Health and Integrated Diagnostics Center (PHIND) held online on December 1st. The seminar covered the capabilities of wearable technologies and Hexoskin to support the early detection of diseases such as the COVID-19 onset.
With over 100 Scientific Publications and validations, Hexoskin has the only clinically validated biometric garment which provides continuous monitoring of numerous and unique physiological parameters. It is an enabling technology for telehealth use cases, such as remote patient monitoring, at-home cardiovascular and pulmonary rehabilitation, and post-acute care.
Along with its smart clothing, Hexoskin offers a unique set of high-resolution biometric data that can continuously monitor activity, sleep, cardiac and respiratory data. Projects in fields such as cardiology, respiratory, behavioral and physiological psychology, biofeedback research, sleep research, and health will be presented during the seminar.
The Hexoskin Connected Health Platform provides researchers with accessible solutions such as the Hexoskin Dashboards, Open API, and Apps to manage, visualize, annotate, analyze, and export raw & processed health data. Data extraction tools allow access to the raw data with time series for machine learning and artificial intelligence projects, making Hexoskin and excellent solution to collect high-resolution data quickly to deliver projects and results. Watch it online today!
We thank all our attendees and Guests Speakers who participated in our Live Webinar on Continuous & Remote Respiratory Monitoring with Hexoskin - In the Era of Chronic Illness, Pandemics & Limited Health Resources, on August 25th, 2020! If you were not able to attend live, and wish to watch it, you can now access the Webinar's recording:
Over 250 guests registered for this panel with our guest speakers Dr. Dennis Jensen (McGill University), and Denise Mannée (Radboud University Medical Center). In this session we discussed the benefits and considerations of digital technologies for Healthcare Providers, Researchers and Patients, and provide real-world evidence of Hexoskin's remote respiratory monitoring capabilities.